Nominal concentration is not the complete exposure
A peptide produces no measurable effect, so the sequence is labeled inactive. That conclusion may be premature if the experiment has not established that the intended material was dissolved and remained available in the assay. Weighed input, stock concentration, and exposure under final assay conditions are related measurements, not interchangeable ones.
Evaluate the final dilution, not just the stock
A stock that appears dissolved can behave differently after dilution into the assay medium. Assess compatibility under the actual buffer and concentration conditions. Supplier solubility resources distinguish results obtained in water, buffered solutions, and organic solvents, illustrating why a solvent-specific observation should not be generalized to every assay formulation.
Control the vehicle across the comparison
If a solvent is required for the stock, include a matched vehicle control and track its final concentration. A dilution series can otherwise change both peptide concentration and solvent exposure. The acceptable vehicle level depends on the biological system and assay; do not borrow a universal threshold without checking compatibility in the experiment being performed.
Use sequence controls with an explicit purpose
A scrambled sequence can be useful, but it may differ from the test peptide in properties that affect solubility or assay behavior. State what the control is intended to test and avoid treating it as automatically matched in every respect. Include a functional assay reference where available so that a negative peptide result is not confused with an unresponsive assay.
Plan material requirements before ordering
When evaluating custom peptide synthesis options, define the exact sequence, terminal state, required modifications, and intended assay conditions. Keep analytical identity and purity separate from solubility or biological activity. A chemically characterized peptide can still require formulation work before it becomes a reliable assay reagent. Ask which product-specific handling information is available rather than assuming one dissolution method fits every sequence.
Qualify the negative result
If exposure has not been established, report no activity under the tested formulation and conditions. If the material was compatible and the assay controls behaved as expected, the negative result becomes more informative. The goal is not to explain every failure as a solubility problem; it is to prevent a preparation problem from being mistaken for a definitive biological conclusion.
Editorial source notes (not part of the article body)
GenScript. Peptide Solubility Testing Service: solvent-specific qualitative and quantitative solubility results.
GenScript. Peptide Handbook: peptide dissolution considerations.
